T. Rowe Price Associates »

Pyxis Oncology shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Pyxis Oncology (PYXS) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Pyxis Oncology

Tip: Access up to 7 years of quarterly data

All positions including Pyxis Oncology held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pyxis Oncology by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2024-09-30 $58k 16k 3.69
2024-06-30 $0 16k 0.00

More positions owned by T. Rowe Price Associates

Microsoft Corp Comm Stk (MSFT)
Apple Comm Stk (AAPL)
Nvidia Corporation Comm Stk (NVDA)
Amazon Comm Stk (AMZN)
Meta Platforms Comm Stk (META)
Eli Lilly & Co Comm Stk (LLY)
Alphabet Comm Stk (GOOGL)
Unitedhealth Group Comm Stk (UNH)
Alphabet Comm Stk (GOOG)
Visa Comm Stk (V)
Mastercard Incorporated Comm Stk (MA)
Netflix Comm Stk (NFLX)
Tesla Comm Stk (TSLA)
Intuitive Surgical Comm Stk (ISRG)
Thermo Fisher Scientific Comm Stk (TMO)

View all positions for T. Rowe Price Associates

Top funds holding Pyxis Oncology

Deep Track Capital
Laurion Capital Management
BlackRock
BlackRock
Balyasny Asset Management
Vanguard Group
Ikarian Capital
Blue Owl Capital Holdings
Geode Capital Management
Standard Life Aberdeen
Stempoint Capital
State Street Corporation
Perceptive Advisors
Superstring Capital Management
683 Capital Management

View all funds holding Pyxis Oncology